Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TOP1 | P11387 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL26623150 | 0.95 | FAAH (0.64) | FAAHTRPV1TERTPTPN1PPARG | |
| Trimethylammonium SCHEMBL4450279 | 0.95 | FAAH (0.64) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL5853539 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL5855889 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2837920 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL514736 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL5854970 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL454819 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL20584432 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL5855886 | 0.92 | FAAH (0.67) | FAAHTRPV1TERTPTPN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4294450-A1 | METHODS FOR PREPARATION OF PLASMID DNA/LIPID PARTICLES WITH DEFINED SIZE FOR IN VITRO AND IN VIVO TRANSFECTION | The Johns Hopkins University (US) | 2023-12-27 | — | — | EP | claimed |
| WO-2023119222-A1 | METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES | POLITECNICO DI TORINO (IT) | 2023-06-29 | — | — | WO | claimed |
| WO-2023064907-A1 | COMPOSITIONS AND METHODS FOR VACCINATION AGAINST PATHOGENIC CORONAVIRUS SPECIES AND VARIANTS | YALE UNIVERSITY (US) | 2023-04-20 | — | — | WO | claimed |
| EP-3697384-A1 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech RNA Pharmaceuticals GmbH (DE) | 2020-08-26 | — | — | EP | claimed |
| WO-2019077053-A1 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2019-04-25 | — | — | WO | claimed |
| WO-2018204421-A2 | MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2018-11-08 | — | — | WO | claimed |
| EP-3277263-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BioNTech RNA Pharmaceuticals GmbH (DE) | 2018-02-07 | — | — | EP | claimed |
| WO-2016156398-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2016-10-06 | — | — | WO | claimed |
| WO-2016155809-A1 | LIPID PARTICLE FORMULATIONS FOR DELIVERY OF RNA AND WATER-SOLUBLE THERAPEUTICALLY EFFECTIVE COMPOUNDS TO A TARGET CELL | BIONTECH RNA PHARMACEUTICALS GMBH (DE) | 2016-10-06 | — | — | WO | claimed |
| EP-3049065-A1 | PARTICLES COMPRISING A SHELL WITH RNA | BioNTech AG (DE) | 2016-08-03 | — | — | EP | claimed |
| EP-2968586-A2 | CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES | Shire Human Genetic Therapies, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| EP-2972360-A1 | SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS | Shire Human Genetic Therapies, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014153052-A9 | CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2015-08-06 | — | — | WO | claimed |
| WO-2015043613-A1 | PARTICLES COMPRISING A SHELL WITH RNA | BIONTECH AG (DE) | 2015-04-02 | — | — | WO | claimed |
| WO-2014153052-A2 | CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| WO-2014144196-A1 | SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS | SHIRE HUMAN GENETIC THERAPIES, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| WO-2014047329-A1 | METHODS FOR USING LIPID PARTICLES | NDSU RESEARCH FOUNDATION (US) | 2014-03-27 | — | — | WO | claimed |
| WO-2011089595-A2 | SUSTAINED-RELEASE NUCLEIC ACID MATRIX COMPOSITIONS | POLYPID LTD. (IL) | 2011-07-28 | — | — | WO | claimed |
| EP-4398882-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| WO-1999047678-A2 | INTERFERON ALPHA PLASMIDS AND DELIVERY SYSTEMS, AND METHODS OF MAKING AND USING THE SAME | VALENTIS, INC. (US) | 1999-09-23 | — | — | WO | disclosed |